$ 645.00
- Products
- Cancer Biomarker ELISA Kits
Cancer Biomarker ELISA Kits
96Trace provides cancer biomarker ELISA kits designed for research-use measurement of proteins involved in tumor biology, cell proliferation, apoptosis, angiogenesis, inflammation, immune regulation and disease progression. These assays support laboratories studying cancer-related pathways, biomarker expression, therapeutic response, tumor microenvironment activity and preclinical oncology models.
Each 96Trace ELISA kit includes essential assay information such as target name, species compatibility, sample type, assay format, detection range and sensitivity. Depending on the selected product, assays may be suitable for serum, plasma, cell culture supernatants, tissue homogenates and other biological research samples. These products help academic, biotechnology and pharmaceutical research teams generate reproducible biomarker data for oncology-focused studies.
$ 645.00
$ 645.00
$ 695.00
$ 715.00
$ 515.00
$ 715.00
$ 545.00
$ 545.00
$ 545.00
$ 715.00
$ 810.00
$ 725.00
$ 695.00
$ 795.00
$ 695.00
$ 715.00
$ 815.00
$ 695.00
$ 715.00
$ 515.00
FAQ
What are cancer biomarker ELISA kits used for?
Cancer biomarker ELISA kits are used to quantify tumor-associated proteins and disease-relevant biomarkers in oncology research, preclinical studies and cancer pathway analysis.
Which cancer research areas can use 96Trace ELISA kits?
96Trace ELISA kits support studies involving tumor growth, apoptosis, angiogenesis, inflammation, immune response, cell signaling and therapeutic biomarker evaluation.
What sample types are commonly used for cancer biomarker ELISA assays?
Depending on the selected kit, common sample types may include serum, plasma, cell culture supernatants, tissue homogenates and other validated biological research samples.
Are 96Trace cancer biomarker ELISA kits for diagnostic use?
No. 96Trace cancer biomarker ELISA kits are intended for research use only and are not intended for diagnostic or therapeutic applications unless explicitly stated.